Effect of the thrombin receptor antagonist (PAR-1) vorapaxar on QT/QTc interval in healthy volunteers: A randomized, placebo- and positive-controlled, parallel group trial
2013 ◽
Vol 3
(1)
◽
pp. 18-24
◽
2013 ◽
Vol 2
(3)
◽
pp. 223-230
◽
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
2015 ◽
Vol 115
(10)
◽
pp. 1325-1332
◽
2017 ◽
Vol 127
(10)
◽
pp. 900-908
◽
Keyword(s):
2016 ◽
Vol 4
(1)
◽
pp. e000123
◽
Keyword(s):